Increasing Communication About Live Donor Kidney Transplant

Kidney Transplant Candidates Clinical Trial

Official title:

Increasing Communication About Live Donor Kidney Transplant: A Proof of Concept

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01855438
• Other study ID #: HM12097
• Secondary ID: PD302305
• Status: Completed
• Phase: N/A
• First received: May 13, 2013
• Last updated: February 19, 2018
• Start date: May 2013
• Est. completion date: April 2016

Study information

• Verified date: February 2018
• Source: Virginia Commonwealth University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will test the efficacy of a communication intervention intended to increase and improve kidney transplant candidates' communication about live donor kidney transplantation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 236
• Est. completion date: April 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Wait listed for kidney transplantation in active status (i.e., status 1 or 2)

• Adult (at least 18 years of age)

• English speaking

• Capable of making medical decisions (i.e., not cognitively impaired)

• Non-institutionalized

Exclusion Criteria:

• Not listed for kidney transplantation or wait listed, but not in active status

• Under 18 years of age

• Non-English speaking

• Cognitively impaired

• Institutionalized

Related Conditions & MeSH terms

• Kidney Transplant Candidates

Intervention

Behavioral:
• Living Donor Transplant Education
The Living Donor Transplant Education informs kidney transplant candidates about living donor transplants and provides guidance in broaching and maintaining discussion about the topic.

Locations

Country	Name	City	State
United States	Virginia Commonwealth University	Richmond	Virginia

Sponsors (2)

Lead Sponsor	Collaborator
Virginia Commonwealth University	Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in the number of individuals screened as potential living donors	1 self-reported item	Upon enrollment (baseline); 1 month post; 3 months post
Secondary	Change in intentions to discuss live donor kidney transplantation	3-item, 7-point Likert-type scale	Upon enrollment (baseline); 1 month post; 3 months post
Secondary	Change in engagement in discussion about live donor kidney transplantation	2 self-reported items: whether live donor kidney transplantation was discussed (yes/no) and number of discussions held	Upon enrollment (baseline); 1 month post; 3 months post
Secondary	Change in the number of living donor kidney transplants performed		At study commencement; after all program sessions (interventions) are completed; at study conclusion